Literature DB >> 6473241

Agranulocytosis during malaria prophylaxis with Maloprim (pyrimethamine and dapsone).

F Booth, L C Barker, C J Barton, R B Naik.   

Abstract

A case of agranulocytosis during malaria prophylaxis with Maloprim (pyrimethamine and dapsone) is described. At the recommended dose of one tablet weekly this is apparently a rare occurrence but highlights one of the hazards in a changing climate of malarial prophylaxis in which the use of Maloprim is increasing.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6473241      PMCID： PMC2417969          DOI： 10.1136/pgmj.60.706.566

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  5 in total

1.  Presumptive fatality due to pyrimethamine-sulfadoxine.

Authors:  D Whitfield
Journal:  Lancet       Date:  1982-12-04       Impact factor: 79.321

2.  Serious reactions during malaria prophylaxis with pyrimethamine-sulfadoxine.

Authors:  V V Olsen; S Loft; K D Christensen
Journal:  Lancet       Date:  1982-10-30       Impact factor: 79.321

3.  Chemoprophylaxis of malaria in Africa.

Authors:  G H Rée
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-12

4.  Agranulocytosis associated with malaria prophylaxis with Maloprim.

Authors:  G Friman; C Nyström-Rosander; G Jonsell; A Björkman; G Lekås; B Svendsrup
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-16

Review 5.  Chemoprophylaxis of malaria in Africa: the spent "magic bullet".

Authors:  L J Bruce-Chwatt
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-11
  5 in total
  1 in total

Review 1.  Ascertainment of risk of serious adverse reactions associated with chemoprophylactic antimalarial drugs.

Authors:  P A Phillips-Howard; A B Bjorkman
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.